4 min read
Brand-Name vs. Generic Drugs: What's Actually Different?
They're required to work the same way in your body. So why does one cost so much more? Here's what's actually different, and what isn't.
Infographic or illustration goes here. Drop one into /public and swap this placeholder for a next/image.
Walk down any pharmacy aisle and you'll see the same medication sold two ways: a brand-name version with a recognizable box, and a generic version that costs a fraction as much. It's natural to wonder if you're getting a lesser product. Here's what the FDA actually requires, side by side.
80-85%
Average cost savings with generics
100%
Same active ingredient, by law
~$0
Marketing costs generics don't carry
| Brand-Name | Generic | |
|---|---|---|
| Active ingredient | Original formula | Identical, by law |
| Inactive ingredients | Company's own formula | May differ slightly |
| FDA approval pathway | New Drug Application (NDA) | Abbreviated New Drug Application (ANDA) |
| Appearance | Patented shape / color | Must look different, by law |
| Average cost | Higher | 80-85% lower |
Quick definition
Bioequivalence: the FDA standard requiring a generic drug to deliver the same amount of active ingredient into the bloodstream, at the same rate, as the brand-name version. It's the legal bar every generic has to clear before it can be sold.
The differences that exist (inactive ingredients, appearance, price) come from patent law and manufacturing economics, not a lower standard of medicine. Once a brand-name drug's patent expires, any manufacturer can apply to sell a bioequivalent version without repeating the original safety and efficacy trials that already proved the drug works.